Wasatch Advisors’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.38M Buy
8,084,419
+1,215,653
+18% +$658K 0.02% 195
2025
Q1
$4.5M Sell
6,868,766
-2,362,739
-26% -$1.55M 0.03% 190
2024
Q4
$9.42M Sell
9,231,505
-10,210,863
-53% -$10.4M 0.05% 163
2024
Q3
$16.8M Sell
19,442,368
-648,202
-3% -$561K 0.08% 134
2024
Q2
$7.2M Sell
20,090,570
-41,754
-0.2% -$15K 0.04% 176
2024
Q1
$13.5M Buy
20,132,324
+7,734,400
+62% +$5.18M 0.07% 148
2023
Q4
$6.74M Sell
12,397,924
-5,588,857
-31% -$3.04M 0.04% 180
2023
Q3
$10.8M Buy
17,986,781
+934,341
+5% +$560K 0.07% 142
2023
Q2
$22.2M Buy
17,052,440
+3,410,023
+25% +$4.43M 0.13% 120
2023
Q1
$24M Buy
13,642,417
+991,663
+8% +$1.75M 0.15% 120
2022
Q4
$39.7M Sell
12,650,754
-471,362
-4% -$1.48M 0.27% 87
2022
Q3
$64.3M Buy
13,122,116
+729,797
+6% +$3.58M 0.45% 67
2022
Q2
$51.3M Buy
12,392,319
+1,815,322
+17% +$7.52M 0.32% 86
2022
Q1
$61.5M Sell
10,576,997
-383,985
-4% -$2.23M 0.3% 86
2021
Q4
$82.2M Buy
10,960,982
+304,940
+3% +$2.29M 0.34% 85
2021
Q3
$96M Buy
10,656,042
+351,747
+3% +$3.17M 0.39% 82
2021
Q2
$123M Sell
10,304,295
-24,128
-0.2% -$289K 0.5% 69
2021
Q1
$129M Buy
10,328,423
+256,042
+3% +$3.21M 0.58% 66
2020
Q4
$157M Buy
10,072,381
+2,963,446
+42% +$46.2M 0.77% 44
2020
Q3
$67.2M Buy
7,108,935
+355,792
+5% +$3.36M 0.43% 75
2020
Q2
$60.5M Buy
6,753,143
+814,709
+14% +$7.3M 0.44% 75
2020
Q1
$37.8M Sell
5,938,434
-1,548,583
-21% -$9.86M 0.39% 71
2019
Q4
$62.7M Buy
7,487,017
+588,494
+9% +$4.93M 0.51% 63
2019
Q3
$62.4M Buy
6,898,523
+299,615
+5% +$2.71M 0.59% 61
2019
Q2
$71.1M Buy
6,598,908
+161,000
+3% +$1.73M 0.69% 55
2019
Q1
$61.4M Buy
6,437,908
+1,359,170
+27% +$13M 0.67% 59
2018
Q4
$58.3M Buy
5,078,738
+534,142
+12% +$6.13M 0.78% 51
2018
Q3
$77M Buy
4,544,596
+486,429
+12% +$8.24M 0.88% 41
2018
Q2
$57.6M Buy
4,058,167
+365,186
+10% +$5.19M 0.69% 54
2018
Q1
$70.2M Sell
3,692,981
-1,005,530
-21% -$19.1M 0.91% 42
2017
Q4
$77.1M Sell
4,698,511
-492,278
-9% -$8.07M 1.02% 36
2017
Q3
$77.9M Sell
5,190,789
-1,739,746
-25% -$26.1M 1.06% 35
2017
Q2
$61M Sell
6,930,535
-129,600
-2% -$1.14M 0.85% 46
2017
Q1
$36.7M Sell
7,060,135
-196,125
-3% -$1.02M 0.54% 56
2016
Q4
$22.1M Buy
7,256,260
+274,579
+4% +$837K 0.33% 73
2016
Q3
$32.3M Buy
6,981,681
+26,920
+0.4% +$125K 0.48% 61
2016
Q2
$40.3M Buy
6,954,761
+1,008
+0% +$5.84K 0.62% 53
2016
Q1
$39.9M Buy
6,953,753
+173,363
+3% +$995K 0.61% 50
2015
Q4
$61.9M Sell
6,780,390
-42,840
-0.6% -$391K 0.85% 35
2015
Q3
$38.5M Buy
6,823,230
+3,731,844
+121% +$21M 0.51% 67
2015
Q2
$34.3M Buy
3,091,386
+30,799
+1% +$342K 0.37% 95
2015
Q1
$48M Buy
3,060,587
+88,528
+3% +$1.39M 0.5% 70
2014
Q4
$45.2M Buy
2,972,059
+1,247
+0% +$19K 0.47% 77
2014
Q3
$32M Buy
2,970,812
+12,866
+0.4% +$139K 0.34% 103
2014
Q2
$45.2M Sell
2,957,946
-167,214
-5% -$2.55M 0.44% 77
2014
Q1
$56.5M Sell
3,125,160
-89,072
-3% -$1.61M 0.55% 54
2013
Q4
$44.6M Buy
3,214,232
+177,174
+6% +$2.46M 0.44% 80
2013
Q3
$31.8M Sell
3,037,058
-71,424
-2% -$749K 0.33% 105
2013
Q2
$24.3M Buy
+3,108,482
New +$24.3M 0.27% 121